|
Dec 7
|
Merck Announces Findings from Phase 2 KeyVibe-002 Trial Evaluating an Investigational Coformulation of Vibostolimab and Pembrolizumab in Previously Treated Patients with Metastatic Non-Small Cell Lung Cancer (NSCLC)
|
|
Dec 6
|
Hedge Funds are Betting on These 14 Sliding Stocks
|
|
Dec 6
|
5 Dividend Stocks That Recently Increased Their Payouts
|
|
Dec 6
|
Merck & Co., Inc.'s (NYSE:MRK) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
|
|
Dec 5
|
25 States with the Lowest Life Expectancy in the US
|
|
Dec 5
|
Macroeconomic Factors Pulled Merck & Co. (MRK) in Q3
|
|
Dec 3
|
Billionaire Ken Fisher’s 10 Stock Picks with Huge Upside Potential
|
|
Dec 2
|
Merck (NYSE:MRK) Is Increasing Its Dividend To $0.77
|
|
Nov 30
|
FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) for the First-Line Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer
|
|
Nov 29
|
12 Best Quality Stocks To Buy Now
|
|
Nov 29
|
AWS and Accenture Help Merck Use Cloud Technology to Reduce Drug Discovery Time and Accelerate Clinical Trial Development
|
|
Nov 29
|
Merck's (MRK) Pneumococcal Jab Shows Upbeat Responses in Study
|
|
Nov 29
|
We Think Merck (NYSE:MRK) Can Stay On Top Of Its Debt
|
|
Nov 28
|
Merck Announces First-Quarter 2024 Dividend
|
|
Nov 28
|
Merck’s V116, an Investigational, 21-valent Pneumococcal Conjugate Vaccine Specifically Designed to Protect Adults, Demonstrated Superior Immunogenicity for 10 of 11 Unique Serotypes Compared to PCV20 in Adults 50 Years of Age and Older
|
|
Nov 25
|
11 Best Fortune 500 Dividend Stocks To Buy Now
|
|
Nov 16
|
FDA Approves Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy as First-Line Treatment for Locally Advanced Unresectable or Metastatic HER2-Negative Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
|
|
Nov 15
|
Alkermes separates cancer drug business as new company Mural
|
|
Nov 14
|
Earnings Estimates Are Falling. These Two Companies Are Shouldering the Blame.
|
|
Nov 14
|
The S&P 500 Has Two Companies to Thank for the Slide in Earnings Estimates
|